{"name":"Feng Tian","slug":"feng-tian","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOR29mV2sta1pvNlZsTVNwWHRyN3dWRHhTVEpTNUZidWEwVHIwZWJhZ0hXcW1xVkVVcUtFRkc3bGt2bTZ3Z2g4LTRpaW92SDRHUDgxekR5SS1TUjhjQjl0NGk5V0Zhd1V4S3MxUWh6SlpDakdJYUhCay10b1NhRTNYRkJZTWFwbnN5amdWZkRuZkxtX2NhS3dpR1U5VDJRNE15bHdNYXU2ZVEyQTZPeTJDTkZiUzlqZXlTQ2p3bXZ4SEdKLUEwdFNrdWhZSjctT2NHTFF3?oc=5","date":"2025-09-29","type":"pipeline","source":"The University of Maryland, Baltimore","summary":"Pharmacy Faculty Awarded $2.63M in Federal Funds for Antibiotic-Resistant Infection Research - The University of Maryland, Baltimore","headline":"Pharmacy Faculty Awarded $2.63M in Federal Funds for Antibiotic-Resistant Infection Research - The University of Marylan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNa3o4UWFqYXU4THA5bUk5c3hFTGNJU2haeHp2NFFlM3JfRHJxdHZYR3FTbVM1S1FJanRWbFVHcWpJQVpGLXh5VGg0TjZWRGdBNG5Vdy01OE4yQWZQdENUWDhiN1NxTUxnSnAwUnlIODlqa25GNWhDX0FsQlVlY1FvT2Vqaks2Q1hOMS1sakZGRmJqUQ?oc=5","date":"2025-09-10","type":"pipeline","source":"The University of Maryland, Baltimore","summary":"UMSOP Faculty Awarded $2.8 Million NIH Grant to Improve Chemotherapy for Triple-Negative Breast Cancer - The University of Maryland, Baltimore","headline":"UMSOP Faculty Awarded $2.8 Million NIH Grant to Improve Chemotherapy for Triple-Negative Breast Cancer - The University ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE10RmVySC1fTWxQc0plc0JUbDhGVXRSNUp3eW9PcmpwZXctZ2U2cXhGbk1sNFIxUi1OZlRMSWMyamxodEJ2T0FZM1dHYzU5T0JZbVpTQzZXZU1MTEdYTFhF?oc=5","date":"2023-05-10","type":"trial","source":"Nature","summary":"A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder - Nature","headline":"A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOYXFTNVIxNm42aHFwNzdGRHd0YjFyX19tUk9lVkFkUE83blNsTjhhMVpUaGFyR0ZXNVNMWm9teF9CdmtQaUpJVjlXTXdfNXp5a2YyQlN1LWxTWnF0d1Bvd3hKOWlSTnlCT1IwVk1TZndCTkZZeUpvcERiNkN1X1cwRUxIaEJVaGpNUjBNRA?oc=5","date":"2022-11-04","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Rubius execs depart as the walls close in - Fierce Biotech","headline":"Chutes & Ladders—Rubius execs depart as the walls close in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNcmJ1b3pPRGNDVDR0Z01mc3JnNWZjclViRVFYOEdHUDVIZlMxcTdBUjZiMDkzNDNhYkxKTUFDTUY4YThKR2xQdHd1b1Z0YklqN1hMMkU0RVNNTVZBeUtsQ2xhQWpOdVNPVTVpeFJ5ZVJTVktOeHE5eWxQWlMyRlJsOU1pUElnU3VOVGxQYnJWSDRNZ2xoVGJsSl9IaEVzUm8?oc=5","date":"2022-08-17","type":"pipeline","source":"Fierce Biotech","summary":"Uncertainty at Ambrx as biotech loses CEO, takes hard look at pipeline - Fierce Biotech","headline":"Uncertainty at Ambrx as biotech loses CEO, takes hard look at pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5TMlFmcnNEYTduZDNGekU1bWNJdkZ2WXFBSlMyOVJQSTdvQ1VNU3c2UTd5RnlMRndMczNJM1R1RlhjWXBvREV4WnpBRVh3LXJwOHhIUFhuV2dkZ19T?oc=5","date":"2022-02-28","type":"pipeline","source":"PNAS","summary":"A general approach to site-specific antibody drug conjugates - PNAS","headline":"A general approach to site-specific antibody drug conjugates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9hckwwekFjTEZ0Y3YzbUV1UGR6N1JRaHE0SS1VOG5tTGQyVmJGSW5tZllJa2J3ZUVSMUxEc2FkalJLbHVPT2NyQmwyMjBwZEdkdDV2M0E4eUxnSDAwUV9v?oc=5","date":"2021-01-06","type":"pipeline","source":"Nature","summary":"KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer - Nature","headline":"KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPNnNBQkZubzdWZTJEbkdFeWRmT2ptWnFJN25fWkh2bXNvUHNDYnc0czJnUVVhTWpLZ3FaNVJuQ3JadWFoMUpLRTNMeDR1elV3cDJhMXI5WFZrTGlXbGdJZWdaZ2k0ZC1EWDZkRmNxczRzdlRTNUdTWUVQUGVfMmgzQ05INzNqWi0xN1FmQWtnYThVQ2VfcTNadUI5dEVSWWlBam9mTlVMYnhjaldtREtpUGdzYTV2SmpCaVNQUC1MYnFlMU1XbjFwcnpEMXVtLTVEZ0xJM1NpVDZvNXpaUHY0bHhLTnQxYUdOOTNyOUlwMURXeWNW?oc=5","date":"2019-10-23","type":"deal","source":"prnewswire.com","summary":"Ambrx and NovoCodex form Second Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugates - prnewswire.com","headline":"Ambrx and NovoCodex form Second Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE13QW0zQkV3Z2w5TEVZbDdNUlBueEhfb0dYSnVfTjBJMzU5R0Q2MlJYY2dLaC1GREt0Yl9SLUNQZ0RjS1pCb3N0dGZnS3A0aV81NEd2dVNB?oc=5","date":"2019-01-28","type":"pipeline","source":"바이오스펙테이터","summary":"Ambrx, Site Specific Technology “Next-Generation ADC → Immuno-Oncology drug” - 바이오스펙테이터","headline":"Ambrx, Site Specific Technology “Next-Generation ADC → Immuno-Oncology drug” - 바이오스펙테이터","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":0,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}